Stonepine-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ENTA",
  "ACAD",
  "ANIP",
  "ADMA",
  "AMRN",
  "GLPG",
  "SLRN",
  "SVRA",
  "THRD",
  "ACET",
  "KROS",
  "ANIK",
  "APRE",
  "BIOA",
  "ESTA",
  "GERN",
  "CALC",
  "KALV",
  "MIST",
  "MYO",
  "NKTX",
  "PMVP",
  "RNXT",
  "SEPN",
  "TELA",
  null,
  "SRZN",
  "WHWK",
  "EDSA",
  "IOVA",
  "AYTU",
  null,
  "IKT",
  "ACRS",
  "ESPR",
  "HRTX",
  null,
  "AQST",
  "INDV.L",
  "SCPH",
  "PROF",
  "EBS",
  "EOLS",
  "XGN",
  null,
  "HLVX",
  "IMAB",
  "ITOS",
  "INO",
  "KZR",
  "URGN",
  "VNDA",
  "VSTM",
  "VIR",
  "XERS",
  "XOMA",
  null,
  "YMAB",
  "ZNTL",
  "ELAN",
  "OPTN",
  "CRGX",
  "CHRS",
  "COLL",
  "CRBP",
  "DAWN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 66
Total Value: 102762727
Accession Number: 0000935836-25-000328
Form Type: 13F-HR
CIK: stonepine-capital-management
Manager Name: Stonepine-Capital-Management

Data Enrichment

92% identified

61 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

66 positions • $102.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 4

Sort by:

MYOMO, INC.

MYO|62857J201

Shares:276.7K

Value:$1.3M

% of Portfolio:1.3% ($1.3M/$102.8M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:100.0K

Value:$1.0M

% of Portfolio:1.0% ($1.0M/$102.8M)

Vir Biotechnology, Inc.

VIR|92764N102

Shares:144.6K

Value:$937.2K

% of Portfolio:0.9% ($937.2K/$102.8M)

scPharmaceuticals Inc.

SCPH|810648105

Shares:347.7K

Value:$914.4K

% of Portfolio:0.9% ($914.4K/$102.8M)

INOVIO PHARMACEUTICALS, INC.

INO|45773H409

Shares:518.3K

Value:$844.9K

% of Portfolio:0.8% ($844.9K/$102.8M)

Profound Medical Corp.

PROF|74319B502

Shares:139.9K

Value:$814.5K

% of Portfolio:0.8% ($814.5K/$102.8M)

GERON CORP

GERN|374163103

Shares:500.0K

Value:$795.0K

% of Portfolio:0.8% ($795.0K/$102.8M)

AYTU BIOPHARMA, INC

AYTU|054754858

Shares:463.7K

Value:$795.0K

% of Portfolio:0.8% ($795.0K/$102.8M)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:212.8K

Value:$738.4K

% of Portfolio:0.7% ($738.4K/$102.8M)

PMV Pharmaceuticals, Inc.

PMVP|69353Y103

Shares:630.2K

Value:$686.9K

% of Portfolio:0.7% ($686.9K/$102.8M)

00439U104

Shares:294.6K

Value:$665.7K

% of Portfolio:0.6% ($665.7K/$102.8M)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:110.0K

Value:$656.7K

% of Portfolio:0.6% ($656.7K/$102.8M)

COLLEGIUM PHARMACEUTICAL, INC

COLL|19459J104

Shares:20.6K

Value:$615.1K

% of Portfolio:0.6% ($615.1K/$102.8M)

CalciMedica, Inc.

CALC|38942Q202

Shares:367.4K

Value:$615.1K

% of Portfolio:0.6% ($615.1K/$102.8M)

49721T507

Shares:200.6K

Value:$603.9K

% of Portfolio:0.6% ($603.9K/$102.8M)

Y-mAbs Therapeutics, Inc.

YMAB|984241109

Shares:131.2K

Value:$581.0K

% of Portfolio:0.6% ($581.0K/$102.8M)

Xeris Biopharma Holdings, Inc.

XERS|98422E103

Shares:102.3K

Value:$561.4K

% of Portfolio:0.5% ($561.4K/$102.8M)

Coherus BioSciences, Inc.

CHRS|19249H103

Shares:620.6K

Value:$500.8K

% of Portfolio:0.5% ($500.8K/$102.8M)

Kezar Life Sciences, Inc.

KZR|49372L209

Shares:100.0K

Value:$488.0K

% of Portfolio:0.5% ($488.0K/$102.8M)

ACELYRIN, Inc.

SLRN|00445A100

Shares:167.6K

Value:$413.9K

% of Portfolio:0.4% ($413.9K/$102.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
MYOMO, INC.(MYOcusip62857J201)	276.7K	QoQ +0.83% (-2.3K) YoY NEW(+276.7K)	All Managers (Combined)	$1.3M	1.3% ($1.3M/$102.8M)	QoQ -24.68% (-$436.3K) YoY NEW(+$1.3M)
Keros Therapeutics, Inc.(KROScusip492327101)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$1.0M	1.0% ($1.0M/$102.8M)	QoQ NEW(+$1.0M) YoY NEW(+$1.0M)
Vir Biotechnology, Inc.(VIRcusip92764N102)	144.6K	QoQ -11.86% (-19.5K) YoY NEW(+144.6K)	All Managers (Combined)	$937.2K	0.9% ($937.2K/$102.8M)	QoQ -22.19% (-$267.3K) YoY NEW(+$937.2K)
scPharmaceuticals Inc.(SCPHcusip810648105)	347.7K	QoQ -49.13% (-335.8K) YoY -22.17% (-99.1K)	All Managers (Combined)	$914.4K	0.9% ($914.4K/$102.8M)	QoQ -62.20% (-$1.5M) YoY -59.22% (-$1.3M)
INOVIO PHARMACEUTICALS, INC.(INOcusip45773H409)	518.3K	QoQ -50.63% (-531.7K) YoY NEW(+518.3K)	All Managers (Combined)	$844.9K	0.8% ($844.9K/$102.8M)	QoQ -56.03% (-$1.1M) YoY NEW(+$844.9K)
Profound Medical Corp.(PROFcusip74319B502)	139.9K	QoQ -30.02% (-60.1K) YoY NEW(+139.9K)	All Managers (Combined)	$814.5K	0.8% ($814.5K/$102.8M)	QoQ -45.77% (-$687.5K) YoY NEW(+$814.5K)
GERON CORP(GERNcusip374163103)	500.0K	QoQ NEW(+500.0K) YoY NEW(+500.0K)	All Managers (Combined)	$795.0K	0.8% ($795.0K/$102.8M)	QoQ NEW(+$795.0K) YoY NEW(+$795.0K)
AYTU BIOPHARMA, INC(AYTUcusip054754858)	463.7K	QoQ +13.78% (+56.2K) YoY -1.85% (-8.7K)	All Managers (Combined)	$795.0K	0.8% ($795.0K/$102.8M)	QoQ +14.74% (+$102.2K) YoY -44.64% (-$641.3K)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	212.8K	QoQ NEW(+212.8K) YoY NEW(+212.8K)	All Managers (Combined)	$738.4K	0.7% ($738.4K/$102.8M)	QoQ NEW(+$738.4K) YoY NEW(+$738.4K)
PMV Pharmaceuticals, Inc.(PMVPcusip69353Y103)	630.2K	QoQ +17.61% (-94.4K) YoY NEW(+630.2K)	All Managers (Combined)	$686.9K	0.7% ($686.9K/$102.8M)	QoQ -15.09% (-$122.2K) YoY NEW(+$686.9K)
(cusip00439U104)✕	294.6K	QoQ NEW(+294.6K) YoY NEW(+294.6K)	All Managers (Combined)	$665.7K	0.6% ($665.7K/$102.8M)	QoQ NEW(+$665.7K) YoY NEW(+$665.7K)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	110.0K	QoQ 0.00% (-0) YoY NEW(+110.0K)	All Managers (Combined)	$656.7K	0.6% ($656.7K/$102.8M)	QoQ -22.26% (-$188.1K) YoY NEW(+$656.7K)
COLLEGIUM PHARMACEUTICAL, INC(COLLcusip19459J104)	20.6K	QoQ NEW(+20.6K) YoY NEW(+20.6K)	All Managers (Combined)	$615.1K	0.6% ($615.1K/$102.8M)	QoQ NEW(+$615.1K) YoY NEW(+$615.1K)
CalciMedica, Inc.(CALCcusip38942Q202)	367.4K	QoQ -21.63% (-101.4K) YoY -29.70% (-155.2K)	All Managers (Combined)	$615.1K	0.6% ($615.1K/$102.8M)	QoQ -62.93% (-$1.0M) YoY -71.70% (-$1.6M)
(cusip49721T507)✕	200.6K	QoQ -0.16% (-323) YoY NEW(+200.6K)	All Managers (Combined)	$603.9K	0.6% ($603.9K/$102.8M)	QoQ -8.93% (-$59.3K) YoY NEW(+$603.9K)
Y-mAbs Therapeutics, Inc.(YMABcusip984241109)	131.2K	QoQ NEW(+131.2K) YoY NEW(+131.2K)	All Managers (Combined)	$581.0K	0.6% ($581.0K/$102.8M)	QoQ NEW(+$581.0K) YoY NEW(+$581.0K)
Xeris Biopharma Holdings, Inc.(XERScusip98422E103)	102.3K	QoQ -43.90% (-80.1K) YoY -82.90% (-495.8K)	All Managers (Combined)	$561.4K	0.5% ($561.4K/$102.8M)	QoQ -9.16% (-$56.6K) YoY -57.52% (-$760.3K)
Coherus BioSciences, Inc.(CHRScusip19249H103)	620.6K	QoQ +148.23% (+370.6K) YoY NEW(+620.6K)	All Managers (Combined)	$500.8K	0.5% ($500.8K/$102.8M)	QoQ +45.16% (+$155.8K) YoY NEW(+$500.8K)
Kezar Life Sciences, Inc.(KZRcusip49372L209)	100.0K	QoQ -9.09% (-10.0K) YoY NEW(+100.0K)	All Managers (Combined)	$488.0K	0.5% ($488.0K/$102.8M)	QoQ -33.98% (-$251.2K) YoY NEW(+$488.0K)
ACELYRIN, Inc.(SLRNcusip00445A100)	167.6K	QoQ +26.12% (-34.7K) YoY NEW(+167.6K)	All Managers (Combined)	$413.9K	0.4% ($413.9K/$102.8M)	QoQ -0.78% (-$3.3K) YoY NEW(+$413.9K)